(S)-3-(2-(((R)-1-(5-(4-Fluoro-3-methylphenyl)pyrimidin-2-yl)ethyl)amino)pyrimidin-4-yl)-4-isopropyloxazolidin-2-one

Catalog No. :
ACPMOD298
CAS No. :
1429179-08-7
Molecular Formula :
C23H25FN6O2
Molecular Weight :
436.49

IUPAC Name:(S)-3-(2-(((R)-1-(5-(4-fluoro-3-methylphenyl)pyrimidin-2-yl)ethyl)amino)pyrimidin-4-yl)-4-isopropyloxazolidin-2-one

(S)-3-(2-(((R)-1-(5-(4-Fluoro-3-methylphenyl)pyrimidin-2-yl)ethyl)amino)pyrimidin-4-yl)-4-isopropyloxazolidin-2-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25mg95%$1312.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-3-(2-(((R)-1-(5-(4-Fluoro-3-methylphenyl)pyrimidin-2-yl)ethyl)amino)pyrimidin-4-yl)-4-isopropyloxazolidin-2-one
IUPAC Name(S)-3-(2-(((R)-1-(5-(4-fluoro-3-methylphenyl)pyrimidin-2-yl)ethyl)amino)pyrimidin-4-yl)-4-isopropyloxazolidin-2-one
Molecular FormulaC23H25FN6O2
Molecular Weight436.49
SMILESO=C1OC[C@H](C(C)C)N1C2=NC(N[C@@H](C3=NC=C(C4=CC=C(F)C(C)=C4)C=N3)C)=NC=C2
InChI KeyJDCYIMQAIKEACU-DNVCBOLYSA-N
Synonym2-Oxazolidinone, 3-[2-[[(1R)-1-[5-(4-fluoro-3-methylphenyl)-2-pyrimidinyl]ethyl]amino]-4-pyrimidinyl]-4-(1-methylethyl)-, (4S)-;(1R)-IDH889
CAS No.1429179-08-7

Synthetic Route by SureRoute

1. ACPMOD298 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEITN214 route compound structure diagram
    ACEITN214139911-27-6 In Stock
  4. Then
  5. ACPMOD298 route product structure diagram
    ACPMOD2981429179-08-7
Inquiry

2. ACPMOD298 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACSQOR760 route compound structure diagram
    ACSQOR7601001200-60-7 In Stock
  4. Then
  5. ACPMOD298 route product structure diagram
    ACPMOD2981429179-08-7
Inquiry

Comments (0)